2026
Press Releases
-
Seattle Children’s Research Institute, Benaroya Research Institute at Virginia Mason Franciscan Health, and GentiBio Highlight Long Standing Scientific Collaboration Advancing GNTI 122 Into the Clinic
-
New Study Links Noncoding DNA Genetic Variants to Root Causes of Rheumatoid Arthritis
-
Regulatory T Cell-Boosting Therapy Impacts Flu Responses — For Better or Worse — Depending on Timing
-
Benaroya Research Institute Awarded $13 Million Across 13 Grants in Last Half of 2025 to Predict, Prevent, Reverse and Cure Immune System Diseases
2025
Press Releases
-
Benaroya Research Institute’s Dr. Peter Linsley Receives Puget Sound Business Journal Lifetime Achievement Award
-
New Genomic Screens Illuminate How Genetic Variants Drive Autoimmune Disease Through T Cells
-
Asthma Exacerbations in Children Caused by Multiple Molecular Pathways
-
Benaroya Research Institute Awarded Over Half a Million Across Two Grants in First Half of 2025 to Predict, Prevent, Reverse, and Cure Immune System Diseases
-
New Clues in Type 1 Diabetes: Immune Cells Target Nuclear Proteins Nonspecific to Pancreas
-
The Sound Life Project – New Finding Identifies Four Categories of Healthy Immune Systems
-
CD4 Memory T Cells may be Responsible for High Efficacy of Shingles Vaccine
-
Benaroya Research Institute Awarded $11 Million Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse and Cure Immune System Diseases
-
Milk-Specific T Cell Suggests that Eosinophilic Esophagitis (EoE) is a Food Allergy
2024
Press Releases
Seattle Children’s Research Institute, Benaroya Research Institute at Virginia Mason Franciscan Health, and GentiBio Highlight Long Standing Scientific Collaboration Advancing GNTI 122 Into the Clinic
New Study Links Noncoding DNA Genetic Variants to Root Causes of Rheumatoid Arthritis
Regulatory T Cell-Boosting Therapy Impacts Flu Responses — For Better or Worse — Depending on Timing
Benaroya Research Institute Awarded $13 Million Across 13 Grants in Last Half of 2025 to Predict, Prevent, Reverse and Cure Immune System Diseases
-
Benaroya Research Institute’s Dr. Peter Linsley Receives Puget Sound Business Journal Lifetime Achievement Award
-
New Genomic Screens Illuminate How Genetic Variants Drive Autoimmune Disease Through T Cells
-
Asthma Exacerbations in Children Caused by Multiple Molecular Pathways
-
Benaroya Research Institute Awarded Over Half a Million Across Two Grants in First Half of 2025 to Predict, Prevent, Reverse, and Cure Immune System Diseases
-
New Clues in Type 1 Diabetes: Immune Cells Target Nuclear Proteins Nonspecific to Pancreas
-
The Sound Life Project – New Finding Identifies Four Categories of Healthy Immune Systems
-
CD4 Memory T Cells may be Responsible for High Efficacy of Shingles Vaccine
-
Benaroya Research Institute Awarded $11 Million Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse and Cure Immune System Diseases
-
Milk-Specific T Cell Suggests that Eosinophilic Esophagitis (EoE) is a Food Allergy
